Curis vs Prothena
Prothena reported revenue of $10 million in fiscal 2025, about the same as Curis' $9 million in fiscal 2025. Curis' revenue fell 13.4% in its latest year, and Prothena's fell 92.8%. Curis had an operating margin of -60.5%, against -2216.4% at Prothena.
Side by side
| Curis | Prothena | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $9M | $10M |
| Revenue growth | −13.4% | −92.8% |
| Revenue growth a year, last 5 years | −2.7% | 60.9% |
| Gross margin | — | — |
| Operating margin | −60.5% | −2,216.4% |
| Net margin | −80.3% | −2,520.6% |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 108.7% | 0.1% |
| Last close | $0.47 | $8.40 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $5,500, sold $0 | bought $7.7 million, sold $135,926 |
| Piotroski F-score | 3 of 8 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CurisProthena
Operating margin
Percent of revenue
CurisProthena
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CurisProthena